Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Clinical trial NCT03543969 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03543969
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)Skin Cancer Skin Melanoma Skin Carcinoma

Start date: 2018-06-14
Primary completion: 2024-12-27
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.